The Zhitong Finance App learned that AstraZeneca (AZN.US) oral breast cancer medication has been approved by the US Food and Drug Administration (FDA). Previously, the agency's advisory committee had voted against the drug, and this approval was a victory for the pharmaceutical company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.